MedTrace Logo

Validation of MMS Test for Cancer Monitoring

NCT02113683 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-06-21

No results posted yet for this study

Summary

The purpose of this study is the validation of MMS test to detect active tumor growth in different cancer types before and after therapy, as well as in the course of therapy and for subsequent relapse control compared to standard methods (clinical examination, imaging, tumor markers). It should be consider whether the MMS test has comparable diagnostic accuracy, and thus can replace more expensive or invasive procedures in future.

Conditions

  • Colo-rectal Cancer
  • Stomach Cancer
  • Melanoma
  • Sarcoma

Sponsors & Collaborators

  • Helios Klinikum Berlin-Buch

    collaborator OTHER

  • MedInnovation GmbH

    lead INDUSTRY

Principal Investigators

  • Katja Waterstradt, PhD · MedInnovation GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2018-06-20
Completion
2018-06-20

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02113683 on ClinicalTrials.gov